M&A Deal Summary

Shanghai MicroPort Medical Acquires Hemovent

On October 4, 2021, Shanghai MicroPort Medical acquired medical products company Hemovent for 123M EUR

Acquisition Highlights
  • This is Shanghai MicroPort Medical’s 1st transaction in the Medical Products sector.
  • This is Shanghai MicroPort Medical’s 0th largest (disclosed) transaction.
  • This is Shanghai MicroPort Medical’s 1st transaction in Germany.

M&A Deal Summary
Date 2021-10-04
Target Hemovent
Sector Medical Products
Buyer(s) Shanghai MicroPort Medical
Deal Type Add-on Acquisition
Deal Value 123M EUR

Target

Hemovent

Aachen, Germany
Hemovent is a medical device company specializing in the development of ground-breaking Extracorporeal Life Support (ECLS) systems, a technology often referred to as Extracorporeal Membrane Oxygenation (ECMO). Hemovent was founded in 2013 and is based in Aachen, Germany.

Search 198,544 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Shanghai MicroPort Medical

Shanghai, China
Category Company
Sector Medical Products
DESCRIPTION

MicroPort Medical is an entrepreneurial, innovative company which provides leading technologies and products to physicians with life-saving solutions and treatments for patients. In close cooperation with recognized international physicians and scientists worldwide, the company has developed a range of interventional vascular products that meet the highest quality and clinical standards.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Germany) 1 of 1
Year (2021) 1 of 1
Mergr

Product

Company

Legal